1J2E |
2.6 |
Crystal structure of Human Dipeptidyl peptidase IV |
1N1M |
2.5 |
Human Dipeptidyl Peptidase IV/CD26 in complex with an inhibitor |
1NU6 |
2.1 |
Crystal structure of human Dipeptidyl Peptidase IV (DPP-IV) |
1NU8 |
2.5 |
Crystal structure of human dipeptidyl peptidase IV (DPP-IV) in complex with Diprotin A (IPI) |
1PFQ |
1.9 |
crystal structure of human apo dipeptidyl peptidase IV / CD26 |
1R9M |
2.1 |
Crystal Structure of Human Dipeptidyl Peptidase IV at 2.1 Ang. Resolution. |
1R9N |
2.3 |
Crystal Structure of human dipeptidyl peptidase IV in complex with a decapeptide (tNPY) at 2.3 Ang. Resolution |
1RWQ |
2.2 |
Human Dipeptidyl peptidase IV in complex with 5-aminomethyl-6-(2,4-dichloro-phenyl)-2-(3,5-dimethoxy-phenyl)-pyrimidin-4-ylamine |
1TK3 |
2.0 |
Crystal Structure Of Human Apo Dipeptidyl Peptidase IV/CD26 |
1TKR |
2.7 |
Human Dipeptidyl Peptidase IV/CD26 inhibited with Diisopropyl FluoroPhosphate |
1U8E |
2.2 |
HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F |
1W1I |
3.03 |
Crystal structure of dipeptidyl peptidase IV (DPPIV or CD26) in complex with adenosine deaminase |
1WCY |
2.2 |
Crystal Structure Of Human Dipeptidyl Peptidase IV (DPPIV) Complex With Diprotin A |
1X70 |
2.1 |
HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINO ACID INHIBITOR |
2AJL |
2.5 |
X-ray Structure of Novel Biaryl-Based Dipeptidyl peptidase IV inhibitor |
2BGN |
3.15 |
HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26) |
2BGR |
2.0 |
Crystal structure of HIV-1 Tat derived nonapeptides Tat(1-9) bound to the active site of Dipeptidyl peptidase IV (CD26) |
2BUB |
2.66 |
Crystal Structure Of Human Dipeptidyl Peptidase IV (CD26) in Complex with a Reversed Amide Inhibitor |
2FJP |
2.4 |
Human dipeptidyl peptidase IV/CD26 in complex with an inhibitor |
2G5P |
2.4 |
Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 21ac |
2G5T |
2.3 |
Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 21ag |
2G63 |
2.0 |
Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-pro) inhibitor 24b |
2HHA |
2.35 |
The structure of DPP4 in complex with an oxadiazole inhibitor |
2I03 |
2.4 |
Crystal structure of human dipeptidyl peptidase 4 (DPP IV) with potent alkynyl cyanopyrrolidine (ABT-279) |
2I78 |
2.5 |
Crystal structure of human dipeptidyl peptidase IV (DPP IV) complexed with ABT-341, a cyclohexene-constrained phenethylamine inhibitor |
2IIT |
2.35 |
Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor |
2IIV |
2.15 |
Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor |
2JID |
2.8 |
Human Dipeptidyl peptidase IV in complex with 1-(3,4-Dimethoxy-phenyl) -3-m-tolyl-piperidine-4-ylamine |
2OAG |
2.3 |
Crystal structure of human dipeptidyl peptidase IV (DPPIV) with pyrrolidine-constrained phenethylamine 29g |
2OGZ |
2.1 |
Crystal structure of DPP-IV complexed with Lilly aryl ketone inhibitor |
2OLE |
2.4 |
Crystal Structure Of Human Dipeptidyl Peptidase IV (DPPIV) Complex With Cyclic Hydrazine Derivatives |
2ONC |
2.55 |
Crystal structure of human DPP-4 |
2OPH |
2.4 |
Human dipeptidyl peptidase IV in complex with an alpha amino acid inhibitor |
2OQI |
2.8 |
Human Dipeptidyl Peptidase IV (DPP4) with Piperidinone-constrained phenethylamine |
2OQV |
2.8 |
Human Dipeptidyl Peptidase IV (DPP4) with piperidine-constrained phenethylamine |
2P8S |
2.2 |
Human dipeptidyl peptidase IV/CD26 in complex with a cyclohexalamine inhibitor |
2QJR |
2.2 |
dipepdyl peptidase IV in complex with inhibitor PZF |
2QKY |
3.1 |
complex structure of dipeptidyl peptidase IV and a oxadiazolyl ketone |
2QOE |
2.3 |
Human Dipeptidyl Peptidase IV in complex with a Triazolopiperazine-based beta amino acid Inhibitor |
2QT9 |
2.1 |
Human dipeptidyl peptidase iv/cd26 in complex with a 4-aryl cyclohexylalanine inhibitor |
2QTB |
2.25 |
Human dipeptidyl peptidase iv/cd26 in complex with a 4-aryl cyclohexylalanine inhibitor |
2RGU |
2.6 |
Crystal structure of complex of human DPP4 and inhibitor |
2RIP |
2.9 |
Structure of DPPIV in complex with an inhibitor |
3BJM |
2.35 |
Crystal structure of human DPP-IV in complex with (1S,3S, 5S)-2-[(2S)-2-AMINO-2-(3-HYDROXYTRICYCLO[3.3.1.13,7]DEC-1- YL)ACETYL]-2-AZABICYCLO[3.1.0]HEXANE-3-CARBONITRILE (CAS), (1S,3S,5S)-2-((2S)-2-AMINO-2-(3-HYDROXYADAMANTAN-1- YL)ACETYL)-2-AZABICYCLO[3.1.0]HEXANE-3-CARBONITRILE (IUPAC), OR BMS-477118 |
3C43 |
2.3 |
Human dipeptidyl peptidase IV/CD26 in complex with a flouroolefin inhibitor |
3C45 |
2.05 |
Human dipeptidyl peptidase IV/CD26 in complex with a fluoroolefin inhibitor |
3CCB |
2.49 |
Crystal Structure of Human DPP4 in complex with a benzimidazole derivative |
3CCC |
2.71 |
Crystal Structure of Human DPP4 in complex with a benzimidazole derivative |
3D4L |
2.0 |
Human dipeptidyl peptidase IV/CD26 in complex with a novel inhibitor |
3EIO |
2.0 |
Crystal Structure Analysis of DPPIV Inhibitor |
3F8S |
2.43 |
Crystal structure of dipeptidyl peptidase IV in complex with inhibitor |
3G0B |
2.25 |
Crystal structure of dipeptidyl peptidase IV in complex with TAK-322 |
3G0C |
2.69 |
Crystal structure of dipeptidyl peptidase IV in complex with a pyrimidinedione inhibitor 1 |
3G0D |
2.39 |
Crystal structure of dipeptidyl peptidase IV in complex with a pyrimidinedione inhibitor 2 |
3G0G |
2.45 |
Crystal structure of dipeptidyl peptidase IV in complex with a pyrimidinone inhibitor 3 |
3H0C |
2.66 |
Crystal Structure of Human Dipeptidyl Peptidase IV (CD26) in Complex with a Reversed Amide Inhibitor |
3HAB |
2.1 |
The structure of DPP4 in complex with piperidine fused benzimidazole 25 |
3HAC |
2.0 |
The structure of DPP-4 in complex with piperidine fused imidazopyridine 34 |
3KWF |
2.4 |
human DPP-IV with carmegliptin (S)-1-((2S,3S,11bS)-2-Amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-3-yl)-4-fluoromethyl-pyrrolidin-2-one |
3KWJ |
2.8 |
Structure of human DPP-IV with (2S,3S,11bS)-3-(3-Fluoromethyl-phenyl)-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ylamine |
3NOX |
2.338 |
Crystal structure of human DPP-IV in complex with Sa-(+)-(6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidin-2-yl)(morpholino)methanone |
3O95 |
2.85 |
Crystal Structure of Human DPP4 Bound to TAK-100 |
3O9V |
2.75 |
Crystal Structure of Human DPP4 Bound to TAK-986 |
3OC0 |
2.7 |
Structure of human DPP-IV with HTS hit (2S,3S,11bS)-3-butyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ylamine |
3OPM |
2.72 |
Crystal Structure of Human DPP4 Bound to TAK-294 |
3Q0T |
2.401 |
Crystal structure of human dpp-iv in complex withsa-(+)- methyl2-(3-(aminomethyl)-4-(2,4-dichlorophenyl)-2-methyl- 7-oxo-5h-pyrrolo[3,4-b]pyridin-6(7h)-yl)acetate |
3Q8W |
3.64 |
A b-aminoacyl containing thiazolidine derivative and DPPIV complex |
3QBJ |
2.21 |
Crystal structure of dipeptidyl peptidase IV in complex with inhibitor |
3SWW |
2.0 |
Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl-5h-pyrrolo[3,4-b]pyridin-7(6h)-one |
3SX4 |
2.6 |
Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(2-methoxyphenyl)- 2-methyl-5h-pyrrolo[3,4-b]pyridin-7(6h)-one |
3VJK |
2.49 |
Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with MP-513 |
3VJL |
2.393 |
Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with a prolylthiazolidine inhibitor #2 |
3VJM |
2.1 |
Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with a prolylthiazolidine inhibitor #1 |
3W2T |
2.36 |
Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with vildagliptin |
3WQH |
2.85 |
Crystal Structure of human DPP-IV in complex with Anagliptin |
4A5S |
1.62 |
CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A NOVAL HETEROCYCLIC DPP4 INHIBITOR |
4DSA |
3.25 |
Crystal Structure of DPP-IV with Compound C1 |
4DSZ |
3.2 |
Crystal Structure of DPP-IV with Compound C2 |
4DTC |
3.0 |
Crystal Structure of DPP-IV with Compound C5 |
4G1F |
2.9 |
Crystal Structure of human Dipeptidyl Peptidase IV in complex with a pyridopyrimidinedione analogue |
4J3J |
3.2 |
Crystal Structure of DPP-IV with Compound C3 |
4JH0 |
2.35 |
Crystal structure of dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) (DPP-IV-WT) complex with bms-767778 AKA 2-(3-(aminomethyl)-4-(2,4- dichlorophenyl)-2-methyl-5-oxo-5,7-dihydro-6h-pyrrolo[3,4- b]pyridin-6-yl)-n,n-dimethylacetamide |
4KR0 |
2.702 |
Complex structure of MERS-CoV spike RBD bound to CD26 |
4L72 |
3.005 |
Crystal structure of MERS-CoV complexed with human DPP4 |
4LKO |
2.43 |
Crystal structure of human DPP-IV in complex with BMS-744891 |
4N8D |
1.65 |
DPP4 complexed with syn-7aa |
4N8E |
2.3 |
DPP4 complexed with compound 12a |
4PNZ |
1.9 |
Human dipeptidyl peptidase IV/CD26 in complex with the long-acting inhibitor Omarigliptin (MK-3102) |
4PV7 |
3.24 |
Cocrystal structure of dipeptidyl-peptidase 4 with an indole scaffold inhibitor |
4QZV |
2.592 |
Bat-derived coronavirus HKU4 uses MERS-CoV receptor human CD26 for cell entry |
5I7U |
1.95 |
Human DPP4 in complex with a novel tricyclic hetero-cycle inhibitor |
5ISM |
2.0 |
Human DPP4 in complex with a novel 5,5,6-tricyclic pyrrolidine inhibitor |
5J3J |
2.75 |
Crystal Structure of human DPP-IV in complex with HL1 |
5KBY |
2.24 |
Crystal structure of dipeptidyl peptidase IV in complex with SYR-472 |
5T4B |
1.76 |
Human DPP4 in complex with a ligand 34a |
5T4E |
1.77 |
Human DPP4 in complex with ligand 19a |
5T4F |
1.9 |
Human DPP4 in complex with ligand 34p |
5T4H |
2.61 |
Human DPP4 in complex with ligand 34n |
5Y7H |
3.0 |
Crystal structure of human DPP4 in complex with inhibitor3 |
5Y7J |
2.521 |
Crystal structure of human DPP4 in complex with inhibitor2 |
5Y7K |
2.512 |
Crystal structure of human DPP4 in complex with inhibitor1 |
5ZID |
3.0 |
Crystal Structure of human DPP-IV in complex with HL2 |
6B1E |
1.77 |
The structure of DPP4 in complex with Vildagliptin |
6B1O |
1.91 |
The structure of DPP4 in complex with Vildagliptin Analog |